Last 7 days
-4.3%
Last 30 days
8.5%
Last 90 days
-2.5%
Trailing 12 Months
-29.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AAPL | 2.5T | 387.5B | 7.89% | -9.00% | 26.24 | 6.44 | 2.44% | -5.35% |
MSFT | 2.0T | 204.1B | 10.90% | -8.33% | 30.39 | 10.04 | 10.38% | -5.25% |
GOOG | 1.3T | 282.8B | 15.34% | -27.18% | 21.72 | 4.6 | 9.78% | -21.12% |
AMZN | 995.9B | 514.0B | 4.86% | -40.50% | -365.88 | 1.94 | 9.40% | -108.16% |
MID-CAP | ||||||||
NYMT | 3.4B | 258.4M | -7.02% | -24.34% | -11.54 | 13.34 | 24.91% | -254.56% |
JBLU | 2.3B | 9.2B | -16.32% | -53.16% | -6.25 | 0.25 | 51.67% | -98.90% |
SMALL-CAP | ||||||||
PLAY | 1.7B | 1.7B | -10.56% | -16.75% | 14.14 | 1 | 61.79% | 371.82% |
TLRY | 1.6B | 602.5M | -7.75% | -62.41% | -2.78 | 2.67 | 18.18% | -18.59% |
MFA | 1.0B | 482.4M | -10.53% | -34.93% | -4.33 | 2.08 | 33.15% | -170.42% |
BYND | 1000.0M | 418.9M | -15.70% | -67.27% | -2.73 | 2.39 | -9.85% | -101.06% |
CGC | 879.9M | 478.9M | -19.31% | -78.37% | -0.28 | 1.84 | -31.50% | -634.70% |
NKLA | 759.1M | 50.8M | -31.98% | -85.06% | -0.97 | 14.94 | 1229.98% | -13.59% |
GPRO | 746.4M | 1.1B | -5.84% | -42.17% | 25.87 | 0.68 | -5.82% | -92.23% |
INO | 214.7M | 10.3M | -28.62% | -74.83% | -0.77 | 20.92 | 478.23% | 7.85% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 6.8% | 383,471,000 | 358,918,000 | 335,630,000 | 306,339,000 | 276,984,000 |
Gross Profit | 6.2% | 338,965,000 | 319,260,000 | 299,996,000 | 276,238,000 | 252,227,000 |
Operating Expenses | 8.0% | 367,064,000 | 339,722,000 | 313,387,000 | 276,189,000 | 241,383,000 |
S&GA Expenses | 9.6% | 292,843,000 | 267,187,000 | 247,458,000 | 217,199,000 | 190,365,000 |
R&D Expenses | 2.3% | 74,221,000 | 72,535,000 | 65,929,000 | 58,990,000 | 51,018,000 |
EBITDA | -41.0% | -21,218,000 | -15,045,000 | -8,826,000 | 3,672,000 | - |
EBITDA Margin | -32.0% | -0.06 | -0.04 | -0.03 | 0.01 | - |
Earnings Before Taxes | -32.9% | -26,185,000 | -19,696,000 | -13,126,000 | -111,000 | 10,685,000 |
EBT Margin | -24.4% | -0.07 | -0.05 | -0.04 | 0.00 | - |
Interest Expenses | -0.3% | 294,000 | 295,000 | 294,000 | 295,000 | 295,000 |
Net Income | -30.9% | -29,267,000 | -22,362,000 | -15,013,000 | -758,000 | 9,840,000 |
Net Income Margin | -22.5% | -0.08 | -0.06 | -0.04 | 0.00 | - |
Free Cahsflow | -13.3% | -23,923,000 | -21,111,000 | -16,066,000 | -7,505,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 3.3% | 504 | 488 | 484 | 484 | 312 |
Current Assets | 3.0% | 423 | 411 | 411 | 413 | 245 |
Cash Equivalents | -27.9% | 60.00 | 84.00 | 80.00 | 187 | 93.00 |
Inventory | 9.8% | 33.00 | 30.00 | 27.00 | 24.00 | 21.00 |
Net PPE | 2.2% | 22.00 | 21.00 | 20.00 | 18.00 | 16.00 |
Liabilities | 19.8% | 87.00 | 73.00 | 70.00 | 65.00 | 72.00 |
Current Liabilities | 32.7% | 56.00 | 42.00 | 41.00 | 36.00 | 43.00 |
Shareholder's Equity | 0.5% | 417 | 415 | 414 | 419 | 239 |
Retained Earnings | -14.1% | -46.85 | -41.05 | -30.90 | -20.71 | -17.58 |
Additional Paid-In Capital | 1.3% | 463 | 457 | 446 | 440 | 257 |
Accumulated Depreciation | 16.1% | 8.00 | 7.00 | 6.00 | 5.00 | - |
Shares Outstanding | 0.8% | 54.00 | 54.00 | 53.00 | 53.00 | 50.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -36.7% | -13.97 | -10.22 | -2.74 | 8.00 | 25.00 |
Share Based Compensation | 12.1% | 29.00 | 26.00 | 31.00 | 28.00 | 25.00 |
Cashflow From Investing | -18.6% | -195 | -164 | -185 | -102 | -51.02 |
Cashflow From Financing | -0.6% | 177 | 178 | 177 | 178 | 4.00 |
88%
65.3%
36%
Y-axis is the maximum loss one would have experienced if Inari Medical was unfortunately bought at previous high price.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | MetLife Investment Management, LLC | reduced | -2.33 | -589,619 | 3,465,800 | 0.03% |
2023-03-17 | American Portfolios Advisors | reduced | -18.08 | -9,618 | 67,483 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -77.71 | -2,513,100 | 608,905 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | unchanged | - | - | - | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -4.87 | -544,429 | 2,702,570 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 21.78 | 289,000 | 4,707,000 | 0.05% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -28.21 | -68,318,000 | 115,352,000 | 0.14% |
2023-02-21 | NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC | reduced | -35.6 | -219,950 | 284,050 | 0.01% |
2023-02-17 | TRUIST FINANCIAL CORP | sold off | -100 | -234,000 | - | -% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | unchanged | - | -746 | 15,254 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 24, 2023 | point72 asset management, l.p. | 4.9% | 2,611,241 | SC 13G | |
Feb 14, 2023 | macquarie group ltd | 3.38% | 1,814,852 | SC 13G/A | |
Feb 14, 2023 | alliancebernstein l.p. | 4.1% | 2,183,673 | SC 13G/A | |
Feb 13, 2023 | capital international investors | 0.1% | 72,099 | SC 13G/A | |
Feb 13, 2023 | milder donald b | 6.0% | 3,225,220 | SC 13G/A | |
Feb 10, 2023 | cvf, llc | 4.8% | 2,591,665 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.07% | 4,331,429 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 9.20% | 4,938,574 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 10.6% | 5,671,100 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 10.6% | 5,671,100 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 11.86 -81.01% | 14.93 -76.09% | 28.86 -53.79% | 47.63 -23.73% | 80.09 28.25% |
Current Inflation | 10.97 -82.43% | 13.60 -78.22% | 25.54 -59.10% | 41.38 -33.74% | 68.77 10.12% |
Very High Inflation | 9.89 -84.16% | 11.99 -80.80% | 21.63 -65.36% | 34.15 -45.32% | 55.78 -10.68% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 21, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | S-8 | Employee Benefits Plan | |
Feb 27, 2023 | 8-K | Current Report | |
Feb 27, 2023 | 10-K | Annual Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-20 | Hykes Andrew | sold | -578,610 | 64.29 | -9,000 | president and ceo |
2023-03-15 | Hoffman William | acquired | 10,700 | 0.428 | 25,000 | - |
2023-03-15 | Hoffman William | sold | -1,580,870 | 63.2348 | -25,000 | - |
2023-03-14 | Hoffman William | sold | -300,500 | 60.1 | -5,000 | - |
2023-03-13 | Hill, Mitch C. | acquired | 2,970 | 0.457 | 6,500 | chief financial officer |
2023-03-13 | Hill, Mitch C. | sold | -747,585 | 58.6341 | -12,750 | chief financial officer |
2023-03-12 | Hoffman William | acquired | - | - | 961,350 | - |
2023-03-12 | Tu Thomas | acquired | - | - | 292,584 | chief medical officer |
2023-03-12 | Hill, Mitch C. | acquired | - | - | 125,393 | chief financial officer |
2023-03-12 | Hykes Andrew | acquired | - | - | 430,517 | president and ceo |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 383,471 | $ 276,984 | $ 139,670 |
Cost of goods sold | 44,506 | 24,757 | 13,106 |
Gross profit | 338,965 | 252,227 | 126,564 |
Operating expenses | |||
Research and development | 74,221 | 51,018 | 18,399 |
Selling, general and administrative | 292,843 | 190,365 | 89,746 |
Total operating expenses | 367,064 | 241,383 | 108,145 |
(Loss) income from operations | (28,099) | 10,844 | 18,419 |
Other income (expense) | |||
Interest income | 1,852 | 154 | 484 |
Interest expense | (294) | (295) | (1,135) |
Change in fair value of warrant liabilities | 0 | 0 | (3,317) |
Other income (expense) | 356 | (18) | (662) |
Total other income (expense) | 1,914 | (159) | (4,630) |
(Loss) income before income taxes | (26,185) | 10,685 | 13,789 |
Provision for income taxes | 3,082 | 845 | 0 |
Net (loss) income | (29,267) | 9,840 | 13,789 |
Other comprehensive income (loss) | |||
Foreign currency translation adjustments | (592) | (379) | 0 |
Unrealized gain (loss) on available-for-sale debt securities | 1,843 | (27) | 4 |
Total other comprehensive income (loss) | 1,251 | (406) | 4 |
Comprehensive (loss) income | $ (28,016) | $ 9,434 | $ 13,793 |
Net (loss) income per share | |||
Basic | $ (0.55) | $ 0.20 | $ 0.43 |
Diluted | $ (0.55) | $ 0.18 | $ 0.27 |
Weighted average common shares used to compute net (loss) income per share | |||
Basic | 52,837,674 | 49,815,914 | 32,033,827 |
Diluted | 52,837,674 | 55,594,159 | 51,554,996 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 60,222 | $ 92,752 |
Short-term investments in debt securities | 266,179 | 83,348 |
Accounts receivable, net | 58,611 | 42,351 |
Inventories, net | 32,581 | 21,053 |
Prepaid expenses and other current assets | 5,312 | 5,694 |
Total current assets | 422,905 | 245,198 |
Property and equipment, net | 21,655 | 16,471 |
Operating lease right-of-use assets | 50,703 | 44,909 |
Deposits and other assets | 8,889 | 981 |
Long-term investments in debt securities | 0 | 3,983 |
Total assets | 504,152 | 311,542 |
Current liabilities | ||
Accounts payable | 7,659 | 6,541 |
Payroll-related accruals | 38,955 | 24,433 |
Accrued expenses and other current liabilities | 8,249 | 10,737 |
Operating lease liability, current portion | 1,311 | 802 |
Total current liabilities | 56,174 | 42,513 |
Operating lease liabilities, noncurrent portion | 30,976 | 28,404 |
Other long-term liability | 0 | 1,416 |
Total liabilities | 87,150 | 72,333 |
Commitments and contingencies (Note 7) | ||
Stockholders' equity | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2022 and 2021 | 0 | 0 |
Common stock, $0.001 par value, 300,000,000 shares authorized as of December 31, 2022 and 2021; 54,021,656 and 50,313,452 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 54 | 50 |
Additional paid in capital | 462,949 | 257,144 |
Accumulated other comprehensive income (loss) | 849 | (402) |
Accumulated deficit | (46,850) | (17,583) |
Total stockholders' equity | 417,002 | 239,209 |
Total liabilities and stockholders' equity | $ 504,152 | $ 311,542 |